Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3454115
Author(s) Liakoni, Evangelia; Dolder, Patrick C; Rentsch, Katharina; Liechti, Matthias E
Author(s) at UniBasel Liechti, Matthias Emanuel
Year 2015
Title Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland
Journal Swiss medical weekly
Volume 145
Pages / Article-Number w14166
Abstract QUESTIONS UNDER STUDY: To describe acute toxicity of recreational drugs including novel psychoactive substances. METHODS: We included all cases presenting at the emergency department (ED) of the University Hospital of Basel, Switzerland, between October 2013 and September 2014 with acute toxicity due to self-reported recreational drug use or with symptoms/signs consistent with acute toxicity. Isolated ethanol intoxications were excluded. Intoxications were confirmed with immunoassays and liquid chromatography coupled with mass spectrometry (LC-MS/MS), which also detected novel psychoactive substances. RESULTS: Among the 47,767 attendances at the ED, 216 were directly related to acute toxicity of recreational drugs. The mean patient age was 31 years and 69% were male. Analytical drug confirmation was available in 180 cases. Most presentations were related to cocaine (36%), cannabis (31%), opioids (13%), 3,4-methylenedioxy-methamphetamine (MDMA, 9%), other amphetamines (7%), benzodiazepines (7%), and lysergic acid diethylamide (LSD, 5%). The substances most commonly detected analytically were cannabis (37%), cocaine (33%), opioids (29%), benzodiazepines (21%), and amphetamines including MDMA (13%). Notably, there were only two cases of novel psychoactive substances (2,5-dimethoxy-4-bromophenethylamine [2C-B] and pentylone). The most frequent symptoms were tachycardia (31%), anxiety (27%), nausea or vomiting (23%), and agitation (22%). Severe complications included myocardial infarction (2), psychosis (10), seizures (10), and 1 fatality. Most patients were discharged home (68%), 8% were admitted to intensive care and 9% were referred to psychiatric care. CONCLUSION: Medical problems related to illicit drugs mostly concerned cocaine and cannabis and mainly involved sympathomimetic toxicity and/or psychiatric disorders. ED presentations associated with novel psychoactive substances appeared to be relatively rare.
Publisher EMH
ISSN/ISBN 1424-7860
edoc-URL http://edoc.unibas.ch/42262/
Full Text on edoc Available
Digital Object Identifier DOI 10.4414/smw.2015.14166
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/26218967
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.338 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024